Copy

NEWSLETTER - JUNE 2022
It has been another incredibly busy three months at VALIDATE. We celebrated our 5th Birthday, had a packed event schedule (with more events to come), awarded our 5th round of Pump-Priming funding, and launched another round of Training Grants.

We are also happy to have welcomed 43 new members to VALIDATE! Our community now has 533 members representing
 254 institutes across 72 countries (44 of which are Lower and Middle-Income). 

Engage with the ever-growing VALIDATE Network by attending our events, via the member's directory, and through our social media.

VALIDATE Pump-Priming Grants Round #5 Awarded

In March, VALIDATE, in partnership with the Collaboration for Tuberculosis Vaccine Discovery (CTVD), awarded round #5 of our Pump-Priming Grants, supporting eight exciting research projects.

The pump-priming grants were for projects of up to £50,000 over 12 months, aiming to lead to relevant and useful data towards tuberculosis vaccine development. For this round all projects were led by an Early Career Researcher (ECR), supporting their career progression.

Find out the details of these funded projects on our website.

VALIDATE Training Grant Awarded
In March, VALIDATE awarded Dr Naomi Daniels, University of Otago, New Zealand a Training Grant. Naomi will use the grant to support a laboratory exchange to Colorado State University in the United States.

Find out about all of our Training Grant recipients 


VALIDATE Training Grant Round #13 Now Open!
Deadline 20 June 2022

VALIDATE offers training grants of up to £3500 to help our post-doc researchers take advantage of training opportunities that will contribute to their continuing professional development. This can include (but is not limited to): attendance at courses or workshops, laboratory exchanges, and work shadowing. 

Applicants must be an Associate member of VALIDATE (and/or a post-doctoral scientist working on research directly related to TB vaccine development nominated by a CTVD member). We particularly welcome applications from researchers based in LMICs.

Find out more, and discover how to apply, via the VALIDATE website.

VALIDATE Events
"A vaccine for...?" Seminar Series
In VALIDATE's "A vaccine for" seminar series, leading experts are providing an overview of the state of vaccine research for VALIDATE's focus pathogens. These talks are aimed at researchers working on other pathogens, as part of VALIDATE's remit to increase cross-pathogen information dissemination, as our focus pathogens have many overlapping characteristics and so research in one field can inform others.
A Vaccine for Leishmaniasis?
6 April 2022
,
Prof Mitali Chatterjee from IPGMER in India and Dr Mohamed Osman from the University of York provided an overview and update on the current state of research into vaccines for leishmaniasis.


You can watch the Seminar on YouTube
A Vaccine for Melioidosis?
18 May 2022

Prof Chiranjay Mukhopadhyay and Dr Somasish Ghost Dastidar from the Kasturba Medical College in India discussed the prospects for a vaccine for Melioidosis.

Youtube video coming soon
VALIDATE Workshop: Fundamentals of Flow Cytometry
On 4 May, 28 VALIDATE members from 11 countries attended a two-day virtual "Fundamentals of Flow Cytometry" workshop provided by the Scottish Society of Cytomics. Flow Cytometry is a useful technology for many of our members, and this course was aimed at ECRs new to flow cytometry and those wishing to consolidate their knowledge. The workshop had excellent feedback from attendees so we may re-run the event - get in touch with the VALIDATE team if this would be of interest to you.
Upcoming VALIDATE Events

VALIDATE ECR Summer Showcase Seminars
22 June 13 July 2022

One of the core aims of VALIDATE is to support its members in career progression. To this end, VALIDATE is hosting an ECR Summer Showcase series of virtual seminars

In each hour session, three VALIDATE Associates will each give a 15-minute presentation about their research, followed by a Q&A. We hope this will be an excellent opportunity for the presenters to showcase their science to their fellow members worldwide and perhaps even inspire new collaborations.

Find details of each seminar and register to attend online.

A Vaccine for Leprosy?
28 June 2022, 16:00 BST 

The third in VALIDATE's "A vaccine for..." seminar series, this session will focus on leprosy. Dr Khushboo Borah and Dr Chyntia Carolina Díaz Acosta will discuss the prospects for a vaccine for leprosy, of which there are still over 200,000 new cases diagnosed every year.

The seminar is open to everyone (including non-members), but will be especially interesting as a quick overview for vaccine researchers who do not study leprosy.

Find out more and register online.

VALIDATE Workshop: Storytelling for Scientists

A key aim of VALIDATE is to increase awareness of our focus pathogens and the diseases they cause, and scientific outreach impacts are becoming increasingly important to scientists, and to funding agencies reviewing grant applications. With this in mind, we have asked First Create The Media to provide our members with training on how to best communicate their scientific research to the general public. In Storytelling for Scientists, our members will delve into the techniques of narrative and storytelling to discover tools and tips to help them communicate their research in a clear, compelling way. This is an excellent opportunity for members wishing to enhance their engagement and science communications skills.

The event is full, but you can add yourself to the waiting list online.
The VALIDATE community has experienced something of a growth spurt in recent weeks with 43 new members joining. Check out their profiles below and perhaps form your next research partnership.

Investigators
Breno Castello Branco Beirão, Federal University of Parana, Brazil
Prof Pere Joan Cardona, Institute Hospital Universitari, Spain
Prof Carlos Martin, Universidad de Zaragoza, Spain
Assoc Prof Sunhee Lee, University of Texas Medical Branch, USA

Associates
Dr Hazem Abdelaal, Seattle Children's Research Institute, USA
Dr Bahareh Bagheri, Stellenbosch University, South Africa
Dr Marwa Hassan, University of Surrey, UK
Dr Kee Woong Kwon, University College of Medicine, South Korea
Dr Socorro Miranda-Hernandez, James Cook University, Australia
Dr Trisha Parbhoo, Stellenbosch University, South Africa
Dr Andy Tran, St George’s University of London, UK
Dr Ana Maria Valencia-Hernandez, James Cook University, Australia
Dr Jia Wang, University of Texas Medical Branch, USA
Dr Rebecca Winsbury, UK Health Security Agency, UK
Dr Guangzu Zhao, James Cook University, Australia


Affiliates
Dr Marcia Ashmi, ICAR-Indian Veterinary Research Institute, India
Miss Alberta Ateere, University of Oxford, UK
Ms María García Bengoa, Unvirsity of Hannover & LIONEX, Germany
Ms Silvia Calvo García, University of Zaragoza, Spain
Ms Jemima Chase, University of Oxford, UK
Dr Joconiah Chirenda, University of Zimbabwe, Zimbabwe
Ms Rebecca Clark, LSHTM, UK
Dr Deb Dutta, National Institute of Mental Health and Neurosciences, India
Dr Tim Fredsgaard-Jones, University of Oxford, UK
Ms Magdalena Godkowicz, University of Lodz, Poland
Ms Claudia Guerrero Perales, University of Zaragoza, Spain
Ms Imke Hinrichs, University of Antwerp, Belgium
Mr Peter Jensen, Norvax, UK
Dr Yumi Maeda, National Institute of Infectious Diseases, Japan
Dr Meera Madhavan, University of Oxford, UK
Mr Islam Matar, Majecules LLC, Egypt
Mr Robert Mitchell, University of Oxford, UK
Ms Naima Nur, North South University, Bangladesh
Ms Rebecca Perez, University of Oxford, UK
Dr Elton Rogozi, Institute of Public Health, Albania
Dr Hiroyuki Saiga, National Institute of Infectious Diseases, Japan
Ms Hannah Scott, University of Oxford, UK
Ms Gillian Singh, Edinburgh University, UK
Mr Sujeet Singh, Central University of Rajasthan, India
Dr Alya Soudani, Institut Pasteur de Tunis, Tunisia
Dr Toshiki Tamura, National Institute of Infectious Diseases, Japan
Ms Himani Tripathi, Central University of Rajasthan, India
Mrs Lindsey Waddell, Roslin Institute, UK

Spread the word!
Remember, VALIDATE membership is free and open to all, so please let colleagues know about the many benefits of membership and how to join our growing community.
EXTERNAL OPPORTUNITIES
Job Opportunities
PUBLICATIONS
A century of attempts to develop an effective tuberculosis vaccine:
Why they failed?
International Immunopharmacology

An alphavirus-derived self-amplifying mRNA encoding PpSP15-LmSTI1 fusion protein for the design of a vaccine against leishmaniasis.
Parasitology International

Dipeptidylcarboxypeptidase of Leishmania donovani: A potential vaccine molecule against experimental visceral leishmaniasis. Cellular Immunology

Identification of immunodominant antigens from the first-generation vaccine against cutaneous leishmaniasis.
Frontiers in Immunology
Transcriptional profiling of macrophages reveals distinct parasite stage-driven signatures during early infection by Leishmania donovani.
Nature Scientific Reports
Do tell us about your papers so we can publicise them
on our Publications Page.
How can VALIDATE help?
VALIDATE has a very busy third quarter of 2022 planned, but we are still very happy to hear from our members about how we can best help your
career or research.

Is there any training we can provide?
Can we put you in touch with a potential collaborator?
Would you like to share details of your research with your peers in VALIDATE?

VALIDATE might be able to help, so get in touch:

validate@ndm.ox.ac.uk
Follow us on social media
      
Copyright © 2022 VALIDATE Network - VAccine deveLopment for complex Intracellular neglecteD pAThogEns. All rights reserved.

Email validate:

validate@ndm.ox.ac.uk

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.